Monitoring Distribution of the Therapeutic Agent Dimethyl Sulfoxide via Solvatochromic Shift of Albumin-Bound Indocyanine Green

We recently developed a novel hyperspectral excitation-resolved near-infrared fluorescence imaging system (HER-NIRF) based on a continuous-wave wavelength-swept laser. In this study, this technique is applied to measure the distribution of the therapeutic agent dimethyl sulfoxide (DMSO) by utilizing...

Full description

Bibliographic Details
Main Authors: Jaedu Cho, Farouk Nouizi, Chang-Seok Kim, Gultekin Gulsen
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Sensors
Subjects:
Online Access:https://www.mdpi.com/1424-8220/23/18/7728
_version_ 1827723608890277888
author Jaedu Cho
Farouk Nouizi
Chang-Seok Kim
Gultekin Gulsen
author_facet Jaedu Cho
Farouk Nouizi
Chang-Seok Kim
Gultekin Gulsen
author_sort Jaedu Cho
collection DOAJ
description We recently developed a novel hyperspectral excitation-resolved near-infrared fluorescence imaging system (HER-NIRF) based on a continuous-wave wavelength-swept laser. In this study, this technique is applied to measure the distribution of the therapeutic agent dimethyl sulfoxide (DMSO) by utilizing solvatochromic shift in the spectral profile of albumin-bound Indocyanine green (ICG). Using wide-field imaging in turbid media, complex dynamics of albumin-bound ICG are measured in mixtures of dimethyl sulfoxide (DMSO) and water. Phantom experiments are conducted to evaluate the performance of the HER-NIRF system. The results show that the distribution of DMSO can be visualized in the wide-field reflection geometry. One of the main purposes of the DMSO is to act as a carrier for other drugs, enhancing their effects by facilitating skin penetration. Understanding the solubility and permeability of drugs in vivo is very important in drug discovery and development. Hence, this HER-NIRF technique has great potential to advance the utilization of the therapeutic agent DMSO by mapping its distribution via the solvatochromic shift of ICG. By customizing the operational wavelength range, this system can be applied to any other fluorophores in the near-infrared region and utilized for a wide variety of drug delivery studies.
first_indexed 2024-03-10T22:03:11Z
format Article
id doaj.art-386dab3e4a274a089b5dfb4e0c9e882f
institution Directory Open Access Journal
issn 1424-8220
language English
last_indexed 2024-03-10T22:03:11Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Sensors
spelling doaj.art-386dab3e4a274a089b5dfb4e0c9e882f2023-11-19T12:53:23ZengMDPI AGSensors1424-82202023-09-012318772810.3390/s23187728Monitoring Distribution of the Therapeutic Agent Dimethyl Sulfoxide via Solvatochromic Shift of Albumin-Bound Indocyanine GreenJaedu Cho0Farouk Nouizi1Chang-Seok Kim2Gultekin Gulsen3Tu and Yuen Center for Functional Onco-Imaging, Department of Radiological Sciences, University of California, Irvine, CA 92697, USATu and Yuen Center for Functional Onco-Imaging, Department of Radiological Sciences, University of California, Irvine, CA 92697, USADepartment of Cogno-Mechatronics Engineering, Pusan National University, Busan 607-735, Republic of KoreaTu and Yuen Center for Functional Onco-Imaging, Department of Radiological Sciences, University of California, Irvine, CA 92697, USAWe recently developed a novel hyperspectral excitation-resolved near-infrared fluorescence imaging system (HER-NIRF) based on a continuous-wave wavelength-swept laser. In this study, this technique is applied to measure the distribution of the therapeutic agent dimethyl sulfoxide (DMSO) by utilizing solvatochromic shift in the spectral profile of albumin-bound Indocyanine green (ICG). Using wide-field imaging in turbid media, complex dynamics of albumin-bound ICG are measured in mixtures of dimethyl sulfoxide (DMSO) and water. Phantom experiments are conducted to evaluate the performance of the HER-NIRF system. The results show that the distribution of DMSO can be visualized in the wide-field reflection geometry. One of the main purposes of the DMSO is to act as a carrier for other drugs, enhancing their effects by facilitating skin penetration. Understanding the solubility and permeability of drugs in vivo is very important in drug discovery and development. Hence, this HER-NIRF technique has great potential to advance the utilization of the therapeutic agent DMSO by mapping its distribution via the solvatochromic shift of ICG. By customizing the operational wavelength range, this system can be applied to any other fluorophores in the near-infrared region and utilized for a wide variety of drug delivery studies.https://www.mdpi.com/1424-8220/23/18/7728fluorescence imagingmultispectral and hyperspectral imagingsolvatochromic shifttunable lasersspectroscopyDMSO sensing
spellingShingle Jaedu Cho
Farouk Nouizi
Chang-Seok Kim
Gultekin Gulsen
Monitoring Distribution of the Therapeutic Agent Dimethyl Sulfoxide via Solvatochromic Shift of Albumin-Bound Indocyanine Green
Sensors
fluorescence imaging
multispectral and hyperspectral imaging
solvatochromic shift
tunable lasers
spectroscopy
DMSO sensing
title Monitoring Distribution of the Therapeutic Agent Dimethyl Sulfoxide via Solvatochromic Shift of Albumin-Bound Indocyanine Green
title_full Monitoring Distribution of the Therapeutic Agent Dimethyl Sulfoxide via Solvatochromic Shift of Albumin-Bound Indocyanine Green
title_fullStr Monitoring Distribution of the Therapeutic Agent Dimethyl Sulfoxide via Solvatochromic Shift of Albumin-Bound Indocyanine Green
title_full_unstemmed Monitoring Distribution of the Therapeutic Agent Dimethyl Sulfoxide via Solvatochromic Shift of Albumin-Bound Indocyanine Green
title_short Monitoring Distribution of the Therapeutic Agent Dimethyl Sulfoxide via Solvatochromic Shift of Albumin-Bound Indocyanine Green
title_sort monitoring distribution of the therapeutic agent dimethyl sulfoxide via solvatochromic shift of albumin bound indocyanine green
topic fluorescence imaging
multispectral and hyperspectral imaging
solvatochromic shift
tunable lasers
spectroscopy
DMSO sensing
url https://www.mdpi.com/1424-8220/23/18/7728
work_keys_str_mv AT jaeducho monitoringdistributionofthetherapeuticagentdimethylsulfoxideviasolvatochromicshiftofalbuminboundindocyaninegreen
AT farouknouizi monitoringdistributionofthetherapeuticagentdimethylsulfoxideviasolvatochromicshiftofalbuminboundindocyaninegreen
AT changseokkim monitoringdistributionofthetherapeuticagentdimethylsulfoxideviasolvatochromicshiftofalbuminboundindocyaninegreen
AT gultekingulsen monitoringdistributionofthetherapeuticagentdimethylsulfoxideviasolvatochromicshiftofalbuminboundindocyaninegreen